Skip to main content
Article
Who Should Receive Extended Infusion Beta-Lactam Therapy?
Journal of the American Academy of Physician Assistants
  • Christopher T. Roman, Butler University
  • Tia Sloth
  • Kendra M. Damer, Butler University
Document Type
Article
Publication Date
1-1-2016
DOI
http://dx.doi.org/10.1097/01.JAA.0000480576.16121.88
Abstract
The increasing prevalence of antibiotic-resistant bacteria challenges a clinician's ability to fight life-threatening infections. Administering beta-lactams via extended infusion may improve patient outcomes. This article discusses the underlying principles of this therapeutic approach and when it may be appropriate.
Rights
Version of record can be found through LWW.
Citation Information
Christopher T. Roman, Tia Sloth and Kendra M. Damer. "Who Should Receive Extended Infusion Beta-Lactam Therapy?" Journal of the American Academy of Physician Assistants Vol. 29 Iss. 3 (2016) p. 25 - 26
Available at: http://works.bepress.com/kendra-damer/1/